Anticoagulation does not increase risk of mortality or ICU admission in hospitalized COVID-19 patients with gastrointestinal bleeding: Results from a New York health system - 14/05/21
Doi : 10.1016/j.clinre.2020.101602
Sheila D. Rustgi
Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Jeong Yun Yang
Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States
Sanjana Luther, Yakira David, Rebekah E. Dixon, Priya K. Simoes, Nikhil A. Kumta ⁎ 
Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
⁎Corresponding author at: Associate Professor of Medicine, Director of Surgical and Bariatric Endoscopy, Henry D. Janowitz Division of Gastroenterology, Mount Sinai Hospital, One Gustave L. Levy Place, Box 1069 New York, NY 10029-6574, United States.Associate Professor of Medicine, Director of Surgical and Bariatric Endoscopy, Henry D. Janowitz Division of Gastroenterology, Mount Sinai HospitalOne Gustave L. Levy Place, Box 1069New YorkNY10029-6574United States
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Keywords : COVID-19, Gastrointestinal bleeding, Anticoagulation
El texto completo de este artículo está disponible en PDF.
Esquema
© 2020
Elsevier Masson SAS. Reservados todos los derechos.
Vol 45 - N° 3
Artículo 101602- mai 2021 Regresar al número
Artículo precedente
- Covid-19 and hepatic injury: A systematic review
- Francesco Serra, Isabella Bonaduce, Nicola De ruvo, Nicola Cautero, Lucio Brugioni, Roberta Gelmini
- Impact of delayed transit in severe COVID 19 critical care patients: A retrospective analysis
- Dominique Prat, Frédéric Jacobs, Olfa Hamzaoui, Charles Damoisel, Benjamin Sztrymf
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.